Physician profile
Preeti Singh
NPI 1154496180
$4,308.79
in general payments reported to CMS, 2019-2025
14 companies · $32.04 in 2025
The $32.04 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $149 · 2022: $3,645 · 2023: $161 · 2024: $197 · 2025: $32.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $3,575.00 | 2022 | |
| Dentsply Sirona INC | $166.60 | 2022-2025 | Suresmile, Cerec, Waveone Gold Conform Fit |
| Tesaro, INC. | $124.99 | 2019 | |
| Sonendo INC | $111.69 | 2021 | |
| Kulzer, LLC | $94.74 | 2024 | |
| Solventum Corporation | $36.38 | 2024-2025 | Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, Clinpro |
| 3m Company | $36.02 | 2023 | Filtek, Scotchbond Universal Plus |
| Straumann USA LLC | $35.62 | 2022 | |
| Gc America INC. | $32.41 | 2021-2024 | G-Premio Bond, G-Aenial, G-Aenial |
| Align Technology, INC. | $31.86 | 2021-2023 | Invisalign |
| Zimvie INC. | $19.19 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $15.95 | 2022 | |
| Ultradent Products INC | $14.77 | 2023 | Opalescence |
| Elevate Oral Care | $13.57 | 2023 | Fluorimax 5000, Advantage Arrest, Fluorimax Mint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.